Glenmede Trust’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$376K Buy
20,608
+6,036
+41% +$128K ﹤0.01% 1028
2026
Q2
$331K Buy
14,572
+12
+0.1% +$275 ﹤0.01% 1136
2026
Q1
$339K Sell
14,560
-2,351
-14% -$50.6K ﹤0.01% 1106
2025
Q4
$338K Buy
+16,911
New +$330K ﹤0.01% 1091
2025
Q1
$355K Buy
+19,562
New +$351K ﹤0.01% 1020
2020
Q4
– Sell
-1,328
Closed -$13K – 1715
2020
Q3
$13K Buy
1,328
+108
+9% +$1.37K ﹤0.01% 1776
2020
Q2
$17K Buy
1,220
+381
+45% +$5.18K ﹤0.01% 1650
2020
Q1
$11K Hold
839
– – ﹤0.01% 2389
2019
Q4
$11K Buy
839
+436
+108% +$5.35K ﹤0.01% 2389
2019
Q3
$4K Buy
403
+127
+46% +$1.52K ﹤0.01% 2705
2019
Q2
$4K Hold
276
– – ﹤0.01% 2689
2019
Q1
$3K Sell
276
-1,370
-83% -$22.2K ﹤0.01% 2746
2018
Q4
$27K Buy
+1,646
New +$26.7K ﹤0.01% 1853

Other funds holding INVA

Glenmede Trust's INVA Position: Q3 2026 in Review

Glenmede Trust increased its Innoviva (INVA) stake by 41% in Q3 2026, buying an estimated $128K and bringing the position to 20,608 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Glenmede Trust first reported a position in INVA in Q4 2018 and has held it in 13 quarters since. 291 funds tracked by Wall St. Rank hold INVA as of Q3 2026.

  • Glenmede Trust held 20,608 shares of Innoviva worth $376K as of Q3 2026.
  • Glenmede Trust bought 6,036 Innoviva shares in Q3 2026, an estimated $128K.
  • Innoviva made up ﹤0.01% of Glenmede Trust's portfolio in Q3 2026, its #1028 holding.
  • Glenmede Trust first reported a position in Innoviva in Q4 2018 and has held it in 13 quarters since.
  • 291 funds tracked by Wall St. Rank held Innoviva as of Q3 2026.

Based on Glenmede Trust's 13F filing for Q3 2026, filed 16 Nov 2026.